Showing results (511-520 of 570) with videos related to
Sort By:
Pageof 57
The Cancer Journal From Scientific American|May 1, 1996
Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiationL J Solin, B McCormick, A Recht, et al.Plos One|November 13, 2018
Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line modelsNicole Pinto, Stephenie D Prokopec, Frederick Vizeacoumar, et al.Oral Oncology|December 9, 2025
NOTCH1 loss promotes chemo and radio-resistance in head and neck cancerMushfiq H Shaikh, Walid Gazala, Cindy Zheng, et al.The Laryngoscope|April 16, 2025
Effect of Serial Intralesional Steroid Injections on Risk of Recurrence in Idiopathic Subglottic StenosisShengjie Ying, Peter Y F Zeng, Kevin Fung, et al.Oncogene|June 9, 2016
Myeloid translocation genes differentially regulate colorectal cancer programsB Parang, A M Bradley, M K Mittal, et al.Oncotarget|June 15, 2018
High-throughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomavirus-positive or negative cell linesFarhad Ghasemi, Morgan Black, Ren X Sun, et al.Oncogene|March 13, 2019
Kaiso is required for MTG16-dependent effects on colitis-associated carcinomaSarah P Short, Caitlyn W Barrett, Kristy R Stengel, et al.Proceedings of the National Academy of Sciences of the United States of America|July 9, 1996
High affinity type I interleukin 1 receptor antagonists discovered by screening recombinant peptide librariesS D Yanofsky, D N Baldwin, J H Butler, et al.Oncogene|May 10, 2019
Correction: Kaiso is required for MTG16-dependent effects on colitis-associated carcinomaSarah P Short, Caitlyn W Barrett, Kristy R Stengel, et al.Science (New York, N.Y.)|June 13, 1997
Peptide agonist of the thrombopoietin receptor as potent as the natural cytokineS E Cwirla, P Balasubramanian, D J Duffin, et al.Pageof 57